The dangerous pneumococcal disease can be fatal to babies and children. Picture: CDC Pediatrician and infectious disease researcher Professor Peter Richmond said declining rates of vaccination ...
Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...
Rates of invasive pneumococcal disease are at their highest levels since 2004. While more effective vaccines have been approved for use in Australia, most at-risk people can't get them ...
“New generation vaccines need to be rolled out through the National Immunisation Program without further delay. We simply can’t risk not having the best available pneumococcal protection ...
Pneumonia can be caused by a virus, bacteria or fungus. Each of these can cause an immune reaction in the tissues of the ...
Prior to COVID-19, pneumococcal vaccines were the largest vaccine market worldwide – estimated at around $8 billion – with Prevnar capturing almost $6 billion of that total in 2020 from its ...
Many vaccines contain trace amounts of neomycin to prevent bacterial contamination during the manufacturing process. As a topical medicament, neomycin elicits a high sensitization rate.
The Holocaust Museum has drawn over 50,000 visitors a year since it opened, most of them Portuguese schoolchildren, said Michael Rothwell, the British-born director of the city’s Jewish museums.
Experts believe three factors may be driving the increase in invasive pneumococcal disease: "The challenge is three-fold," added Professor Richmond. "We're seeing a drop in vaccine coverage alongside ...
It is important to consolidate data on PCV10 and PCV13 impact on invasive pneumococcal disease (IPD) in all ages to determine persistent vaccine-type serotypes and the main replacement non-vaccine ...
Here, the authors report immunogenicity and safety of AR-MPXV5, a penta-component mRNA vaccine, in naive and simian immunodeficiency virus infected nonhuman primates (NHPs), and demonstrate ...